| Elizabeth Hodits, | |
|
1000 Central St, Evanston, IL 60201-1777 | |
| (847) 570-1260 | |
| Not Available |
| Full Name | Elizabeth Hodits |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 1000 Central St, Evanston, Illinois |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1245690742 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 146012418 (Illinois) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Elizabeth Hodits, 1523 S Kaspar Ave, Arlington Heights, IL 60005-3555 Ph: (847) 650-8811 | Elizabeth Hodits, 1000 Central St, Evanston, IL 60201-1777 Ph: (847) 570-1260 |
News Archive
The Maryland Stem Cell Research Commission has completed its evaluation of the 141 applications in response to its three official Requests for Applications during the FY 2010 funding cycle. The board of directors of the Maryland Technology Development Corporation reviewed the Commission's recommendations and approved 42 projects totaling $11.7 million in funding through the Maryland Stem Cell Research Fund under the Maryland Stem Cell Research Act of 2006.
In a recent study, researchers at the Public Health Agency of Canada found that dry fog fumigation using peracetic acid (PAA) completely deactivated SARS-CoV-2 on all nine of their test surfaces.
OphthaliX Inc., a clinical-stage company focused on developing products that treat and improve sight for people living with ophthalmic disorders, and a subsidiary of Can-Fite BioPharma Ltd., announced today it has launched an updated website, www.ophthaliX.com, to reflect its definitive agreement to acquire Israel-based Improved Vision Systems Ltd.
Mylan N.V. today announced the U.S. launch of Bexarotene 75mg Capsules, which is the generic version of Valeant's Targretin Capsules. This product is indicated for the treatment of cutaneous manifestations of cutaneous t-cell lymphoma in patients who are refractory to at least one prior systemic therapy.
ARIAD Pharmaceuticals, Inc. (Nasdaq: ARIA) today announced data from a Phase 1 clinical trial evaluating oral ridaforolimus, its investigational mTOR inhibitor, in combination with bevacizumab (Avastin®) in heavily pretreated patients with refractory metastatic solid tumors. The data were presented at the Joint Multidisciplinary Congress of the 15th annual European Cancer Organization (ECCO) and the 34th annual European Society of Medical Oncology (ESMO) taking place in Berlin, Germany.
› Verified 4 days ago
Eliana R Lehrman, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 733 Chicago Ave Unit 211, Evanston, IL 60202 Phone: 216-571-2101 | |
Mccabe Speech And Language Services Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1740 Ridge Ave, Ll11b, Evanston, IL 60201 Phone: 847-869-2615 Fax: 847-869-4881 | |
Dr. Robyn M Newman, PHD, CCC-SLP/L Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2951 Central St Apt 301, Evanston, IL 60201 Phone: 224-558-4784 | |
Dr. Jill E Senner, PHD Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2530 Ridge Ave, Evanston, IL 60201 Phone: 847-682-1596 | |
Mrs. Jennifer Preschern, MA CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2606 Park Pl, Evanston, IL 60201 Phone: 847-424-9973 | |
Julia R Irons, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1500 Mcdaniel Ave, Evanston, IL 60201 Phone: 847-859-3000 | |
Ms. Amy Michele Robke, M.A., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1000 Central St, Suite 101, Evanston, IL 60201 Phone: 847-570-2060 Fax: 847-733-5348 |